D.E. Shaw & Co’s Unity Biotechnology UBX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-1,015
| Closed | -$15K | – | 4493 |
|
|
2021
Q4 | $15K | Sell |
1,015
-10,527
| -91% | -$156K | ﹤0.01% | 3905 |
|
|
2021
Q3 | $346K | Buy |
11,542
+6,032
| +109% | +$181K | ﹤0.01% | 3001 |
|
|
2021
Q2 | $256K | Buy |
+5,510
| New | +$256K | ﹤0.01% | 3159 |
|
|
2021
Q1 | – | Sell |
-1,555
| Closed | -$81K | – | 3205 |
|
|
2020
Q4 | $81K | Buy |
+1,555
| New | +$81K | ﹤0.01% | 2657 |
|
|
2020
Q3 | – | Sell |
-1,560
| Closed | -$135K | – | 2791 |
|
|
2020
Q2 | $135K | Buy |
+1,560
| New | +$135K | ﹤0.01% | 2513 |
|
|
2020
Q1 | – | Sell |
-3,471
| Closed | -$250K | – | 2867 |
|
|
2019
Q4 | $250K | Buy |
+3,471
| New | +$250K | ﹤0.01% | 2431 |
|
|
2018
Q4 | – | Sell |
-1,122
| Closed | -$183K | – | 2739 |
|
|
2018
Q3 | $183K | Buy |
+1,122
| New | +$183K | ﹤0.01% | 2395 |
|